No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Celltrion’s Application for Biosimilar Aflibercept Indication Extension Under Review in Australia
On 24 September 2025, , Australia’s Therapeutic Goods Administration (TGA) updated its online list of prescription medicines for evaluation for the months of July, August and September.